This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Acute generalized exanthematous pustulosis
L12_AGEP
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1691 |
4. Check minimum number of eventsNone |
1691 |
5. Include endpointsNone |
1691 |
6. Filter based on genotype QC (FinnGen only) |
1691 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Acute generalized exanthematous pustulosis
based on the number of shared cases.
Similar with more cases:
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1691 | 1109 | 582 |
| Unadjusted period prevalence (%) | 0.34 | 0.38 | 0.26 |
| Median age at first event (years) | 54.97 | 52.29 | 60.07 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1515
- Matched controls
- 15151
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
6234.8
323.0
1318
18
L53.8
ICD-10 Finland
Other specified erythematous conditions
309.2
139.9
140
5
H02AB06
ATC
prednisolone; systemic
3.6
119.3
964
4965
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
5.6
107.9
355
785
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.6
73.5
284
722
XQ800
NOMESCO Finland
Prick test
4.9
72.1
260
614
R06AE07
ATC
cetirizine; oral
2.5
64.5
825
4851
J01FF01
ATC
clindamycin; systemic
2.8
64.5
543
2511
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.1
59.0
395
1557
E0000UV
ATC
NA
2.4
55.7
738
4300
L50.0
ICD-10 Finland
Allergic urticaria
8.9
55.2
122
148
XQ802
NOMESCO Finland
Epicutan test
6.1
53.8
155
278
69599
ICD-8 Finland
Erythematous condition, Other and unspecified
+∞
52.4
50
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
50.5
738
4436
D07AC01
ATC
betamethasone; topical
2.4
50.5
609
3332
XQ820
NOMESCO Finland
Exposure to medicinal substance
31.2
45.2
60
20
R50.9
ICD-10 Finland
Fever, unspecified
2.9
44.9
312
1234
D07AB08
ATC
desonide; topical
3.2
43.4
257
910
T78.4
ICD-10 Finland
Allergy, unspecified
4.8
42.2
148
332
XQ899
NOMESCO Finland
Other assessment of skin
20.7
36.3
54
27
L50.9
ICD-10 Finland
Urticaria, unspecified
5.2
35.9
116
237
E000001
ATC
NA
2.3
35.2
396
2016
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
34.2
219
808
A02BC02
ATC
pantoprazole; systemic
2.0
33.4
979
7317
D07AA02
ATC
hydrocortisone; topical
2.5
31.4
283
1278
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
6.7
30.7
80
125
A46
ICD-10 Finland
Erysipelas
2.6
30.1
246
1051
C01CA24
ATC
epinephrine; parenteral
3.4
29.9
153
481
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
29.7
353
1825
J01MA12
ATC
levofloxacin; systemic
2.3
29.4
317
1565
XQ801
NOMESCO Finland
Intracutantest
20.0
27.5
41
21
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
27.2
526
3294
D07AC13
ATC
mometasone; topical
2.0
26.6
464
2792
D07AB02
ATC
hydrocortisone butyrate; topical
1.9
26.1
474
2891
J01DB01
ATC
cefalexin; oral
2.0
25.2
1234
10441
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.1
25.1
100
254
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.5
24.8
215
943
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.7
24.4
181
728
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
23.8
366
2085
J01MA14
ATC
moxifloxacin; systemic
2.8
23.3
163
632
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.6
23.2
109
320
L04AX01
ATC
azathioprine; systemic
3.6
22.4
105
307
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
22.4
107
318
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
22.2
239
1166
H02AB07
ATC
prednisone; oral
2.2
22.1
247
1225
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
6.2
22.1
60
100
ZX120
NOMESCO Finland
Intravenous
2.6
22.1
178
748
ZX108
NOMESCO Finland
Inhalation
14.7
21.7
36
25
N02AX02
ATC
tramadol; systemic, rectal
1.7
21.6
608
4224
P01BA02
ATC
hydroxychloroquine; oral
2.6
21.3
165
678
H02AB02
ATC
dexamethasone; systemic
2.5
20.5
175
758
D07AD01
ATC
clobetasol; topical
2.1
20.3
244
1247
J01MA02
ATC
ciprofloxacin; systemic
1.7
20.3
568
3923
A04AA01
ATC
ondansetron; systemic, rectal
3.0
19.9
123
439
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
19.6
336
1972
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
11.9
19.3
35
30
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.9
19.0
80
214
D02AX
ATC
Other emollients and protectives
3.9
19.0
79
209
L04AD01
ATC
ciclosporin; systemic
5.8
19.0
54
96
E000003
ATC
NA
3.3
19.0
100
321
N03AG01
ATC
valproic acid; systemic, rectal
2.9
18.8
117
421
J01DA01
ATC
[U] cefalexin; systemic
1.6
18.7
924
7401
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.8
18.6
121
448
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
18.6
425
2741
L04AA06
ATC
mycophenolic acid; systemic
6.7
18.5
47
72
XW000
NOMESCO Finland
Bone marrow biopsy
3.5
18.3
87
258
N02AA05
ATC
oxycodone; systemic
2.1
18.1
218
1110
TQW80
NOMESCO Finland
Local dermatologic skincare
4.4
18.1
66
155
N02BE01
ATC
paracetamol; systemic, rectal
1.8
18.1
1256
11025
C03CA01
ATC
furosemide; systemic
1.8
18.0
397
2525
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
18.0
225
1167
R06.0
ICD-10 Finland
Dyspnoea
1.8
17.5
366
2287
L27.2
ICD-10 Finland
Dermatitis due to ingested food
7.4
17.3
41
57
H02AB04
ATC
methylprednisolone; systemic
2.0
17.2
233
1248
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
17.0
182
881
L04AX04
ATC
lenalidomide; oral
19.5
16.9
25
13
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
16.8
129
528
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
16.7
129
529
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
16.7
224
1193
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.0
16.7
101
357
153
Kela drug reimbursment
Lenalidomid
18.1
16.5
25
14
L27.1
ICD-10 Finland
Localized skin eruption due to drugs and medicaments
18.1
16.5
25
14
R03AC02
ATC
salbutamol; inhalant
1.6
16.2
758
5889
E000006
ATC
NA
2.4
16.0
138
600
J05AB11
ATC
valaciclovir; oral
2.0
15.9
208
1093
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.8
15.7
52
111
J01FA06
ATC
roxithromycin; oral
1.6
15.5
575
4203
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
15.4
331
2078
R06AX27
ATC
desloratadine; oral
1.7
15.4
417
2802
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.5
15.4
124
522
JN4BD
NOMESCO Finland
Extensive body CT
2.2
15.1
165
805
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.4
14.8
125
537
M04AA01
ATC
allopurinol; systemic
2.1
14.7
181
927
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
14.6
638
4830
J01FA10
ATC
azithromycin; systemic
1.5
14.6
850
6881
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.1
14.5
174
883
N03AF01
ATC
carbamazepine; oral, rectal
2.9
14.5
89
318
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.0
14.5
58
150
E000002
ATC
NA
2.0
14.4
193
1026
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.0
14.3
196
1050
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.1
14.1
80
270
J01FA09
ATC
clarithromycin; systemic
1.6
14.0
452
3172
J01AA02
ATC
doxycycline; systemic
1.6
14.0
1073
9214
N03AX16
ATC
pregabalin; oral
1.7
13.8
337
2189
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
13.7
516
3756
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.9
13.6
83
296
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
13.5
147
713
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
13.4
331
2153
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.5
13.3
61
177
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.0
13.3
79
277
P01AB01
ATC
metronidazole; oral, rectal
1.5
13.2
564
4223
Z51.5
ICD-10 Finland
Palliative care
2.7
13.1
92
357
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
16.9
13.0
20
12
L03AA02
ATC
filgrastim; parenteral
3.9
13.0
53
140
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.6
12.9
58
166
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
12.9
134
640
R01AD08
ATC
fluticasone; nasal
1.6
12.8
407
2828
XQ848
NOMESCO Finland
Dermatological photography
3.7
12.7
54
148
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
12.7
248
1502
J05AB01
ATC
aciclovir; systemic
1.7
12.7
311
2017
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
12.6
571
4318
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
12.6
136
658
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.0
12.6
50
129
6959X
ICD-9 Finland
Erythematous conditions, Unspecified erythematous condition
+∞
12.5
12
*
R06AE09
ATC
levocetirizine; oral
1.8
12.5
218
1270
L51.0
ICD-10 Finland
Nonbullous erythema multiforme
24.5
12.5
17
7
N03AX14
ATC
levetiracetam; systemic
3.7
12.4
54
151
R03BA02
ATC
budesonide; inhalant
1.7
12.4
260
1610
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.2
12.2
132
641
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
12.2
299
1938
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
12.2
290
1865
L51.9
ICD-10 Finland
Erythema multiforme, unspecified
16.0
12.1
19
12
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
12.1
176
962
L26
ICD-10 Finland
Exfoliative dermatitis
18.2
12.1
18
10
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
11.6
614
4776
J02AC01
ATC
fluconazole; systemic
1.5
11.6
567
4340
L50.8
ICD-10 Finland
Other urticaria
4.1
11.5
44
110
SPAT1263
SPAT
Sampling
1.5
11.5
612
4765
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
11.3
470
3464
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
11.3
131
654
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.5
11.2
52
154
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
11.1
151
807
A07EC01
ATC
sulfasalazine; oral, rectal
2.1
11.1
126
626
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.1
11.0
42
105
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.3
11.0
98
435
1CX01
NOMESCO Finland
NA
43.6
10.9
13
*
B01AB05
ATC
enoxaparin; parenteral
1.5
10.8
398
2849
N03AF02
ATC
oxcarbazepine; oral
3.0
10.7
62
215
A02BC05
ATC
esomeprazole; systemic
1.5
10.6
530
4050
XG410
NOMESCO Finland
Flow-volume spirometry
2.8
10.6
68
252
R03DC03
ATC
montelukast; oral
1.7
10.6
228
1415
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
6.4
10.6
27
43
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.2
10.5
106
499
WX002
NOMESCO Finland
Sedation and analgesia
1.7
10.5
264
1716
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.6
10.4
46
131
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
10.4
270
1767
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
10.4
83
348
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
10.4
246
1574
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
6.4
10.3
26
41
WW500
NOMESCO Finland
Blood transfusion
2.7
10.3
70
269
N03AX12
ATC
gabapentin; oral
1.7
10.3
214
1318
D05BB02
ATC
acitretin; oral
3.7
10.2
43
118
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
10.2
180
1050
C90.0
ICD-10 Finland
Multiple myeloma
6.3
10.2
26
42
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.6
10.1
71
277
N03AX09
ATC
lamotrigine; oral
2.5
10.1
78
323
N05BA04
ATC
oxazepam; oral
1.5
10.0
341
2395
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
9.9
246
1589
D07XC01
ATC
betamethasone, combinations; topical
1.8
9.9
162
922
JN4AD
NOMESCO Finland
Body CT examination
2.1
9.9
108
526
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
9.9
131
690
C07AB07
ATC
bisoprolol; oral
1.4
9.8
586
4624
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.1
9.8
51
166
L27.9
ICD-10 Finland
Dermatitis due to unspecified substance taken internally
55.3
9.7
11
*
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
55.3
9.7
11
*
C91.4
ICD-10 Finland
Hairy-cell leukaemia
55.3
9.7
11
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
9.6
559
4385
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
9.5
360
2582
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.8
9.5
59
213
R01AD09
ATC
mometasone; nasal
1.4
9.5
612
4891
AA1AD
NOMESCO Finland
CT of head and brain
1.6
9.5
307
2125
L40.1
ICD-10 Finland
Generalized pustular psoriasis
100.6
9.4
10
*
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.7
9.4
63
239
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.3
9.4
46
143
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
9.4
236
1534
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
9.3
241
1579
A03
ICPC
Fever
1.6
9.2
240
1574
Z71.8
ICD-10 Finland
Other specified counselling
1.5
9.2
325
2295
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.3
9.1
81
360
S97
ICPC
Chronic ulcer skin
2.3
9.1
81
360
L04AB04
ATC
adalimumab; parenteral
3.5
9.1
40
115
M54.5
ICD-10 Finland
Low back pain
1.5
9.1
435
3275
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
9.0
149
851
L50.1
ICD-10 Finland
Idiopathic urticaria
7.1
9.0
21
30
L20.0
ICD-10 Finland
Besnier prurigo
2.0
9.0
110
562
H02AB09
ATC
hydrocortisone; systemic
3.2
9.0
45
143
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.5
8.9
39
112
L30.3
ICD-10 Finland
Infective dermatitis
2.9
8.9
53
190
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.0
8.8
119
634
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
4.0
8.8
33
83
127
Kela drug reimbursment
Transplant complication
4.4
8.7
30
69
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
8.7
107
550
SPAT1255
SPAT
Intravenous administration of medicine
2.1
8.7
95
462
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
8.7
204
1296
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.7
8.7
57
216
A02BC03
ATC
lansoprazole; oral
1.5
8.7
392
2912
R06AX22
ATC
ebastine; oral
1.6
8.7
235
1553
Z88.1
ICD-10 Finland
Personal history of allergy to other antibiotic agents
50.3
8.7
10
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.8
8.7
52
187
M05BX04
ATC
denosumab; parenteral
2.4
8.7
73
318
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
8.6
361
2638
J01XX08
ATC
linezolid; systemic
7.7
8.6
19
25
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.4
8.6
69
291
S88
ICPC
Dermatitis contact/allergic
3.3
8.6
42
131
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.7
8.6
55
205
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.0
8.6
49
168
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
8.6
103
523
D02AE01
ATC
carbamide; topical
2.0
8.6
101
510
L04AA01
ATC
[U] ciclosporin; systemic
3.9
8.6
33
85
S18
ICPC
Laceration/cut
1.4
8.4
546
4342
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
8.4
173
1061
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.9
8.4
124
683
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
8.4
219
1435
A04AA02
ATC
granisetron; systemic, transdermal
2.2
8.4
88
422
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.9
8.4
131
735
J45.1
ICD-10 Finland
Nonallergic asthma
2.0
8.4
104
538
ZX112
NOMESCO Finland
Subcutaneous
3.5
8.3
37
108
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.8
8.3
26
55
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
8.2
83
393
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.9
8.2
47
163
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.8
8.2
52
193
C08CA01
ATC
amlodipine; oral
1.4
8.1
425
3247
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
8.0
386
2897
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
8.0
175
1092
A28
ICPC
Limited function/disability NOS
1.7
8.0
186
1181
S01GX01
ATC
cromoglicic acid; ophthalmic
1.5
8.0
274
1915
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.3
8.0
68
298
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
7.3
8.0
18
25
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.1
7.9
41
134
M79.6
ICD-10 Finland
Pain in limb
1.4
7.9
474
3707
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
3.6
7.9
34
97
329
Kela drug reimbursment
Lenalidomide
13.1
7.9
13
10
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.3
7.9
72
325
D07CC01
ATC
betamethasone and antibiotics; topical
1.7
7.9
174
1091
UJF32
NOMESCO Finland
Coloscopy
1.5
7.8
328
2394
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
7.8
330
2412
L04AA13
ATC
leflunomide; oral
3.0
7.7
44
151
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
7.7
207
1365
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.9
7.7
106
569
R60.0
ICD-10 Finland
Localized oedema
1.7
7.7
144
858
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.1
7.6
39
127
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.9
7.6
29
75
SPAT1254
SPAT
Administration of medicine
1.6
7.6
209
1389
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.0
7.5
40
134
N05BB01
ATC
hydroxyzine; systemic
2.0
7.5
97
508
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
7.5
65
288
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.6
7.5
32
91
R11
ICD-10 Finland
Nausea and vomiting
1.8
7.5
116
651
TK800
NOMESCO Finland
Hemodialysis
3.4
7.4
34
102
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.4
7.4
62
270
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.1
7.4
82
406
M25.5
ICD-10 Finland
Pain in joint
1.4
7.4
372
2811
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
7.4
96
503
TGC00
NOMESCO Finland
Bronchial lavation
3.2
7.4
37
119
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
7.4
379
2874
R4110
NOMESCO Finland
Physiotherapy
1.4
7.4
339
2520
M05BA04
ATC
alendronic acid; oral
1.8
7.3
115
647
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
8.4
7.3
15
18
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
7.3
196
1292
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
9.4
7.3
14
15
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.9
7.3
107
590
EMB30
NOMESCO Finland
Adenotomy
2.6
7.2
50
196
N05CF01
ATC
zopiclone; oral
1.4
7.1
411
3183
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
7.1
124
724
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.6
7.1
174
1119
134
Kela drug reimbursment
General erythroderma
12.1
7.1
12
10
A02BA02
ATC
ranitidine; systemic
1.5
7.1
246
1724
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
8.8
7.0
14
16
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
7.0
52
211
A92
ICPC
Allergy/allergic reaction NOS
2.5
7.0
52
211
R02
ICPC
Shortness of breath/dyspnoea
1.7
7.0
159
1003
GD1AD
NOMESCO Finland
Thorax CT examination
2.4
7.0
58
251
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.2
6.9
34
108
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
6.9
186
1226
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
6.9
142
870
A02BC01
ATC
omeprazole; systemic
1.4
6.9
351
2656
J01CA04
ATC
amoxicillin; systemic
1.4
6.8
1153
10562
S76
ICPC
Skin infection other
2.1
6.8
70
334
128
Kela drug reimbursment
Cancers of female genital organs
3.5
6.8
30
88
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
4.2
6.8
24
58
B01AC04
ATC
clopidogrel; oral
1.6
6.8
180
1184
R51.80
ICD-10 Finland
Headache
1.6
6.8
202
1367
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
6.8
688
5828
WW200
NOMESCO Finland
Immunization
2.6
6.7
47
185
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.1
6.7
69
330
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
6.7
351
2671
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.9
6.7
98
539
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
6.6
159
1018
H05AA02
ATC
teriparatide; parenteral
6.5
6.6
16
25
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.7
6.6
43
163
B01AB10
ATC
tinzaparin; parenteral
1.9
6.6
94
513
M01CB01
ATC
sodium aurothiomalate; parenteral
3.8
6.6
26
70
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
6.6
126
757
R53
ICD-10 Finland
Malaise and fatigue
1.5
6.6
268
1938
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
6.6
211
1452
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
6.6
687
5835
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
3.3
6.6
30
91
R81
ICPC
Pneumonia
2.6
6.5
44
172
D07BC01
ATC
betamethasone and antiseptics; topical
1.6
6.5
155
991
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
5.0
6.5
19
38
R42
ICD-10 Finland
Dizziness and giddiness
1.4
6.5
280
2050
L52
ICD-10 Finland
Erythema nodosum
5.3
6.5
18
34
L30.0
ICD-10 Finland
Nummular dermatitis
2.5
6.5
47
192
J47
ICD-10 Finland
Bronchiectasis
3.5
6.4
28
82
6960A
ICD-9 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
14.4
6.4
10
7
R03AC03
ATC
terbutaline; inhalant
1.6
6.4
186
1248
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
3.7
6.4
26
72
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
6.4
466
3743
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.0
6.4
82
429
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
3.3
6.4
29
88
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
6.6
6.3
15
23
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.3
6.3
54
238
L93.0
ICD-10 Finland
Discoid lupus erythematosus
6.0
6.3
16
27
K12.10
ICD-10 Finland
Stomatitis NOS
11.1
6.3
11
10
A07AA02
ATC
nystatin; oral
1.9
6.3
84
449
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
9.3
6.3
12
13
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.2
6.3
62
294
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
6.2
89
485
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.6
6.2
153
986
SPAT1262
SPAT
Handing over of treatment supplies
1.5
6.2
215
1505
A07AA09
ATC
vancomycin; oral
4.5
6.2
20
45
X57
ICD-10 Finland
Unspecified privation
3.0
6.1
33
113
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.8
6.1
110
646
318
Kela drug reimbursment
Teriparatide
5.8
6.1
16
28
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.9
6.1
35
122
WZC30
NOMESCO Finland
Teaching
1.6
6.1
161
1058
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
6.1
207
1442
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
6.1
174
1164
M03BX02
ATC
tizanidine; oral
1.3
6.1
789
6883
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
4.9
6.0
18
37
L04AC05
ATC
ustekinumab; parenteral
10.1
6.0
11
11
N03AX18
ATC
lacosamide; systemic
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1154
8025
2.38
58.83
16.2
8.9
4.2
4.1
e9/l
1.37
1057
7009
279
1046
3.00
54.63
4.4
2.9
10.2
10.5
g/l
0.35
267
955
1003
6726
2.21
53.59
12.1
6.0
26.9
28.2
%
3.25
949
6268
993
6635
2.20
53.51
11.4
5.8
58.2
57.1
%
2.03
940
6206
112
225
5.26
53.21
2.0
1.7
—
—
—
0
0
131
316
4.41
49.91
2.1
1.6
—
—
—
0
0
117
259
4.78
49.60
7.5
5.6
333.7
301.4
iu/ml
0.07
23
34
127
310
4.35
47.63
2.1
1.6
—
—
—
0
0
430
2141
2.35
46.71
2.3
1.8
—
—
—
0
0
325
1435
2.57
45.88
6.4
4.1
245.8
248.0
u/l
0.10
304
1355
1000
6949
2.07
45.50
9.5
6.0
10.6
11.3
umol/l
1.03
964
6579
143
410
3.72
42.89
2.8
1.6
0.2
0.2
g/l
0.29
133
390
62
86
7.45
42.55
2.7
2.8
—
—
—
0
0
145
423
3.66
42.39
2.7
1.6
1.2
1.2
g/l
0.63
138
398
954
6673
1.99
40.75
11.2
6.6
1.2
1.2
mmol/l
0.64
810
5646
62
94
6.81
39.25
2.6
2.6
12.9
11.6
%
0.22
25
51
881
6056
1.95
38.93
9.6
6.0
1.2
1.2
mmol/l
2.19
807
5483
1308
10388
2.14
37.31
13.8
7.2
81.0
78.4
u/l
1.00
1259
9752
223
901
2.70
37.23
1.6
1.3
398.8
210.6
u/ml
1.24
209
824
81
175
4.81
35.28
2.1
1.6
—
—
—
0
0
228
964
2.58
34.62
1.9
1.6
—
—
—
0
0
68
129
5.45
34.34
2.0
1.7
—
—
—
0
0
71
141
5.21
34.09
2.0
1.7
—
—
—
0
0
147
496
3.15
34.00
2.4
1.9
1.3
1.9
ug/l
0.35
132
439
87
209
4.33
33.22
3.6
3.5
704.3
1725.9
u/ml
—
8
17
302
1484
2.26
32.69
2.2
1.8
—
—
—
0
0
71
148
4.96
32.25
2.0
1.6
—
—
—
0
0
299
1473
2.25
32.12
2.0
1.7
—
—
—
0
0
824
5788
1.83
31.67
7.9
4.7
34.6
35.7
g/l
5.86
765
5386
298
1474
2.24
31.67
3.5
2.8
1.9
1.8
%
0.37
265
1309
50
78
6.58
30.80
1.7
1.4
7.2
5.9
ug/l
0.71
45
63
382
2115
2.04
30.18
5.7
3.5
0.8
0.8
mmol/l
1.69
363
1971
55
98
5.77
29.69
1.7
1.7
—
—
—
0
0
375
2075
2.04
29.61
2.9
2.4
11.9
13.2
umol/l
3.16
346
1909
265
1287
2.26
29.29
2.9
2.0
340.6
374.3
nmol/l
1.89
250
1182
123
411
3.15
28.86
3.0
2.9
—
—
—
0
0
1165
9232
1.84
28.71
5.9
4.5
30.8
2429.6
e6/l
—
10
124
330
1764
2.08
28.52
3.0
2.4
21.4
23.0
%
1.23
279
1507
81
207
4.06
28.49
3.1
3.3
1.6
1.3
%
0.32
69
169
348
1918
2.03
27.58
2.9
2.4
2.3
2.3
g/l
1.26
317
1774
465
2832
1.89
27.44
2.0
1.5
2.2
2.3
g/l
0.45
325
1707
1241
10101
1.86
27.17
7.3
4.0
15.2
12.0
mm/h
9.08
1167
9330
126
443
2.99
27.06
1.9
1.6
196.5
146.3
titre
—
10
16
139
517
2.84
26.96
1.4
1.2
0.3
1.3
u/ml
0.99
12
42
324
1754
2.05
26.92
9.1
5.6
1.1
1.1
mmol/l
0.74
301
1619
709
4925
1.76
26.92
4.4
3.5
48.1
43.2
ng/l
0.16
513
3287
1013
7860
1.72
25.12
6.9
4.7
6.7
6.6
mmol/l
0.14
972
7298
233
1140
2.21
25.08
11.3
7.3
9.8
9.4
mmol/l
0.39
221
1088
516
3327
1.79
24.91
4.0
2.6
3937.4
5935.0
umol/l
0.55
455
2882
219
1053
2.24
24.58
5.3
2.9
66.0
66.6
g/l
0.49
200
956
29
31
9.50
24.45
2.0
2.1
—
—
—
0
0
81
231
3.63
24.40
1.9
1.4
—
—
—
0
0
68
172
4.08
24.26
1.9
1.5
—
—
—
0
0
581
3914
1.74
23.88
2.7
2.2
163.5
230.6
u/l
1.46
551
3682
559
3747
1.73
23.26
4.0
3.1
0.3
0.4
e6/l
0.62
453
2833
549
3668
1.74
23.08
3.6
3.0
1625.0
1242.7
ng/l
0.99
474
3097
603
4147
1.71
22.74
3.5
2.4
54.1
56.7
u/l
1.16
565
3825
48
97
5.06
22.61
3.5
2.7
603.2
587.4
e6/l
0.05
42
86
892
6801
1.66
22.60
5.0
3.6
0.0
0.0
estimate
0.50
182
1279
115
426
2.82
22.44
1.7
1.6
3.5
0.2
iu/ml
0.56
17
83
47
94
5.11
22.40
3.6
2.8
0.2
0.2
e9/l
0.19
42
85
529
3523
1.73
22.36
2.8
2.2
3.1
3.0
mg/l
0.91
446
2983
65
169
3.96
22.35
1.8
1.5
—
—
—
0
0
470
3057
1.74
21.46
2.1
1.8
1.3
1.1
mg/l
0.79
374
2324
894
6901
1.63
20.91
5.1
3.6
0.0
0.0
estimate
0.80
186
1264
85
276
3.19
20.91
4.3
3.7
59.4
57.0
%
0.78
85
276
887
6834
1.63
20.91
6.6
4.9
0.0
0.0
estimate
0.50
193
1302
114
437
2.72
20.84
4.0
1.9
—
—
—
0
0
108
411
2.74
20.02
2.8
3.2
3.7
3.6
g/l
0.47
101
390
81
265
3.16
19.68
3.9
3.5
4.4
4.1
e9/l
0.56
81
265
46
102
4.61
19.44
2.4
2.3
607.5
705.3
e6/l
0.35
21
43
50
119
4.30
19.35
1.9
1.5
—
—
—
0
0
50
119
4.30
19.35
1.9
1.5
—
—
—
0
0
50
119
4.30
19.35
1.9
1.5
—
—
—
0
0
234
1262
1.99
19.22
3.1
2.3
0.2
0.2
g/l
0.17
210
1174
67
199
3.46
19.01
1.8
1.4
—
—
—
0
0
438
2880
1.70
18.85
3.5
2.5
4.7
6.6
e6/l
3.55
400
2537
43
93
4.72
18.73
2.1
1.6
—
—
—
0
0
131
567
2.42
18.64
2.1
1.9
1.6
1.5
g/l
0.54
118
490
51
129
4.05
18.23
3.5
2.9
59.1
55.2
%
0.47
39
92
758
5746
1.58
18.22
2.8
2.3
75.4
77.0
nmol/l
0.83
696
5159
329
2030
1.77
17.64
2.6
2.2
29.7
29.7
s
0.01
317
1966
98
380
2.68
17.52
1.4
1.3
—
—
—
0
0
1522
13792
2.04
17.28
27.6
13.5
21.3
23.0
mg/l
1.61
1351
10837
85
309
2.84
17.19
1.5
1.3
—
—
—
0
0
128
576
2.32
16.67
2.3
2.0
38.0
38.9
u/l
0.19
114
510
96
378
2.63
16.66
5.6
4.0
7.8
1.7
ratio
0.62
11
31
106
440
2.50
16.50
2.2
2.2
174.7
427.4
ug/l
1.34
95
414
809
6333
1.53
16.17
3.8
2.8
161.7
113.6
ug/l
1.45
745
5858
93
368
2.62
15.98
2.3
2.1
13.2
11.5
mg/l
0.61
87
335
80
293
2.82
15.96
1.7
1.3
357.7
234.0
u/ml
1.83
52
166
169
867
2.05
15.86
6.8
4.2
5.1
5.2
kpa
0.26
159
815
96
388
2.56
15.80
5.7
4.0
51.7
67.4
mg/l
0.38
74
317
163
828
2.07
15.70
6.7
4.2
1.7
1.8
mmol/l
0.12
125
626
36
78
4.69
15.67
3.3
2.6
31.6
43.1
%
1.80
15
24
96
390
2.55
15.64
5.7
4.0
45.5
62.2
mg/l
0.32
74
320
19
21
9.14
15.56
1.2
2.8
—
—
—
0
0
475
3329
1.59
15.39
3.2
2.3
—
—
—
0
0
26
44
5.99
14.80
1.4
1.4
—
—
—
0
0
49
142
3.52
14.48
1.3
1.2
—
—
—
0
0
155
797
2.04
14.43
1.5
1.5
—
—
—
0
0
71
260
2.81
14.19
1.9
1.5
119.9
111.6
u/ml
0.43
17
47
74
278
2.74
14.10
1.6
1.2
3.3
5.5
u/ml
—
8
22
87
355
2.53
14.06
1.6
1.2
28.7
7.4
u/ml
0.96
24
61
86
349
2.54
14.06
1.6
1.2
17.5
2.5
u/ml
0.57
17
41
22
33
6.74
14.04
1.2
1.2
—
—
—
0
0
91
381
2.47
13.93
1.6
1.2
23.7
37.1
u/ml
0.32
12
20
682
5268
1.49
13.82
5.4
3.8
—
—
—
0
0
82
329
2.57
13.72
1.5
1.5
—
—
—
0
0
588
4418
1.51
13.58
5.4
3.1
33.5
31.3
u/l
0.53
556
4210
36
88
4.16
13.51
1.6
1.4
39.4
20.1
u/ml
—
5
18
170
926
1.93
13.42
2.4
2.4
21.4
24.8
au/ml
0.16
12
59
211
1235
1.81
13.29
6.3
4.2
5.8
5.8
kpa
0.48
205
1194
74
287
2.65
13.27
1.8
1.4
—
13.3
—
0
6
157
837
1.97
13.20
1.3
1.3
40.6
43.0
au/ml
—
8
42
147
766
2.01
13.18
1.9
1.6
—
—
—
0
0
815
6565
1.47
13.15
5.3
4.0
—
—
—
0
0
209
1229
1.80
12.95
6.3
4.2
2.0
1.8
mmol/l
0.48
176
973
276
1765
1.67
12.67
3.1
2.4
125.9
114.8
ug/g
0.32
217
1383
27
55
4.97
12.65
2.2
1.6
—
—
—
0
0
27
55
4.97
12.65
2.2
1.6
—
—
—
0
0
398
2788
1.56
12.55
1.6
1.6
—
—
—
0
0
27
56
4.88
12.39
2.3
1.6
—
—
—
0
0
335
2262
1.60
12.35
3.1
2.7
1.0
1.1
e6/l
0.31
210
1272
117
575
2.11
12.29
8.1
4.6
24.7
24.8
mmol/l
0.15
109
547
32
77
4.22
12.27
2.2
1.5
—
—
—
0
0
112
543
2.14
12.19
2.4
1.9
—
—
—
0
0
606
4661
1.47
12.13
4.4
3.4
2.3
2.4
mmol/l
1.73
532
4079
30
70
4.35
11.96
2.2
1.5
—
—
—
0
0
30
70
4.35
11.96
2.2
1.5
—
—
—
0
0
30
70
4.35
11.96
2.2
1.5
—
—
—
0
0
30
70
4.35
11.96
2.2
1.5
—
—
—
0
0
449
3260
1.51
11.92
1.3
1.3
1.1
1.6
u/ml
0.58
105
847
66
256
2.64
11.85
2.1
1.6
—
—
—
0
0
103
490
2.17
11.76
2.0
1.8
—
—
—
0
0
28
63
4.50
11.68
2.4
1.6
—
—
—
0
0
232
1448
1.70
11.62
9.0
7.8
5.0
5.1
kpa
1.04
217
1387
232
1448
1.70
11.62
9.0
7.8
12.4
12.3
kpa
0.10
216
1387
354
2460
1.56
11.45
1.9
1.7
1214.8
1182.1
nmol/l
0.26
273
1846
231
1450
1.69
11.32
8.9
7.8
1.1
1.1
mmol/l
0.06
176
1134
493
3683
1.48
11.28
5.9
3.9
0.0
0.0
estimate
1.28
179
1262
357
2497
1.54
11.19
4.6
3.7
126.2
385.9
ng/l
3.47
260
1877
240
1528
1.67
11.13
4.6
2.8
6.5
8.0
umol/l
0.86
208
1315
342
2376
1.55
11.03
1.3
1.3
25.8
28.8
iu/ml
0.27
104
752
27
63
4.34
10.78
2.4
1.6
—
—
—
0
0
219
1374
1.68
10.73
4.5
3.2
—
—
—
0
0
68
289
2.41
10.14
1.5
1.4
—
—
—
0
0
140
789
1.84
9.94
8.1
7.3
24.7
24.5
mmol/l
0.32
130
741
63
261
2.47
9.93
1.9
1.4
—
—
—
0
0
677
5466
1.40
9.81
2.2
2.0
95.9
95.5
pmol/l
0.07
402
2814
21
43
4.93
9.79
3.5
2.2
—
—
—
0
0
76
347
2.25
9.63
1.5
1.4
—
—
—
0
0
241
1600
1.59
9.38
10.1
6.8
103.9
104.3
mmol/l
0.66
235
1559
77
359
2.20
9.29
2.1
1.6
—
—
—
0
0
322
2286
1.50
9.25
1.2
1.3
13.7
11.3
u/ml
0.22
121
878
408
3036
1.45
9.25
5.0
4.0
1.0
1.0
kg/l
0.12
51
438
1500
14001
1.63
9.20
27.7
15.4
139.4
139.6
mmol/l
3.17
1474
13612
302
2119
1.52
9.17
3.3
2.9
4.4
2.8
e6/l
1.11
173
1135
189
1188
1.67
9.16
10.3
8.5
118.5
120.1
g/l
0.51
181
1148
27
72
3.79
9.07
1.1
1.0
—
—
—
0
0
96
492
2.01
9.05
4.3
2.6
3.6
3.8
g/l
0.91
66
362
96
493
2.00
9.00
4.3
2.6
7.4
7.4
g/l
0.20
68
378
96
493
2.00
9.00
4.3
2.6
—
—
—
0
0
52
207
2.56
8.93
1.2
1.2
—
—
—
0
0
1500
14028
1.61
8.80
28.1
15.6
4.0
4.0
mmol/l
0.25
1474
13617
169
1044
1.69
8.74
6.8
3.6
4.8
4.6
kpa
0.50
163
1006
235
1585
1.56
8.51
21.6
25.2
1.4
1.3
inr
0.46
26
203
43
160
2.73
8.45
1.6
1.7
55.9
57.0
%
0.06
30
107
24
62
3.91
8.43
1.3
1.2
—
—
—
0
0
42
155
2.75
8.38
2.9
2.0
33.2
32.4
pg
0.65
42
155
49
197
2.53
8.27
1.2
1.3
—
—
—
0
0
63
286
2.25
8.14
1.6
1.2
56.2
54.1
u/ml
—
9
27
84
429
2.01
8.03
3.5
2.8
1.8
1.3
g/l
0.30
71
377
1207
10888
1.38
7.97
4.8
4.1
14.9
14.7
pmol/l
1.72
1101
9930
169
1070
1.64
7.96
7.0
3.5
1.2
1.2
mmol/l
0.43
150
915
88
462
1.95
7.79
1.6
1.8
—
—
—
0
0
65
306
2.17
7.70
1.9
1.7
30333.3
13122.2
e6/l
0.78
49
224
36
129
2.83
7.61
1.1
1.2
70.5
52.7
u/l
0.40
25
90
175
1133
1.61
7.53
9.1
7.3
1.6
1.4
mmol/l
1.00
168
1085
24
68
3.57
7.43
2.4
3.6
—
—
—
0
0
56
252
2.26
7.41
3.3
2.4
15.8
16.2
%
0.30
29
128
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
77
396
1.99
7.24
3.7
3.2
0.3
0.4
u/ml
0.64
47
220
86
460
1.92
7.22
4.7
2.7
10.3
10.3
g/l
0.04
78
393
10
13
7.73
7.12
1.2
1.2
—
—
—
0
0
1010
8941
1.32
7.09
4.7
3.0
56.7
45.1
u/l
2.99
947
8357
162
1046
1.61
7.05
3.8
2.9
164.6
205.8
ng/l
0.74
147
956
80
422
1.94
7.01
1.3
1.3
—
—
—
0
0
162
1048
1.60
7.00
4.0
2.7
63.2
66.3
ml/min/173m2
0.44
72
414
372
2853
1.39
6.88
1.7
1.7
116346594.7
30297037.5
pmol/l
0.83
312
2360
73
380
1.96
6.66
3.5
2.7
0.1
0.0
g/l
0.37
67
350
162
1061
1.58
6.65
5.3
3.8
107.4
84.6
ng/l
1.60
141
932
85
466
1.87
6.65
3.7
2.7
3.2
3.2
g/l
0.02
67
368
505
4085
1.34
6.61
3.6
3.2
7.0
7.5
mmol/l
2.01
423
3438
11
9
12.29
6.58
2.0
4.4
—
—
—
0
0
24
74
3.28
6.56
1.6
1.3
—
—
—
0
0
91
512
1.82
6.56
7.0
6.1
1.5
1.6
%
0.16
85
482
32
117
2.77
6.55
1.3
1.3
—
—
—
0
0
75
399
1.92
6.43
1.3
1.5
254.5
292.6
ug/g
0.88
42
229
111
668
1.71
6.36
12.0
11.0
—
—
—
0
0
24
76
3.19
6.30
1.6
1.3
—
—
—
0
0
482
3898
1.33
6.26
4.5
4.0
9.1
8.6
mg/mmol
0.09
299
2438
34
132
2.61
6.22
1.3
1.5
—
—
—
0
0
38
156
2.47
6.21
1.2
1.1
—
—
—
0
0
11
19
5.82
6.11
2.8
1.7
—
—
—
0
0
403
3187
1.35
6.06
1.7
1.5
19.3
20.8
nmol/l
1.11
350
2702
40
172
2.36
5.93
1.6
1.4
—
—
—
0
0
25
85
2.97
5.85
1.4
1.3
—
—
—
0
0
40
174
2.33
5.79
1.6
1.4
—
—
—
0
0
40
174
2.33
5.79
1.6
1.4
—
—
—
0
0
29
109
2.69
5.67
1.7
1.5
39.2
34.3
%
0.27
22
70
45
208
2.20
5.66
1.4
1.4
25.3
24.9
u/l
0.03
40
172
27
98
2.78
5.64
1.5
1.1
19.4
1.8
u/ml
—
7
5
10
17
5.91
5.63
1.3
1.4
—
—
—
0
0
75
418
1.83
5.61
1.2
1.1
—
—
—
0
0
18
51
3.56
5.61
6.7
4.5
—
—
—
0
0
182
1271
1.48
5.58
2.8
2.3
37.1
39.3
u/l
0.12
158
1070
30
116
2.61
5.56
4.3
2.6
—
—
—
0
0
39
171
2.31
5.55
1.6
1.4
—
—
—
0
0
39
171
2.31
5.55
1.6
1.4
—
—
—
0
0
1361
12743
1.35
5.51
21.8
12.3
81.5
82.6
ml/min/173m2
0.93
1177
10387
108
672
1.65
5.49
6.3
4.8
24.7
23.9
mmol/l
1.94
97
614
39
172
2.30
5.48
1.6
1.4
—
—
—
0
0
1024
9239
1.27
5.46
3.6
3.2
—
—
—
0
0
1365
12792
1.35
5.45
5.7
4.8
2.0
2.0
mu/l
0.07
1262
11756
29
112
2.62
5.40
2.2
1.1
—
—
—
0
0
73
410
1.82
5.34
1.5
1.5
13.0
10.2
u/l
0.80
60
331
65
355
1.86
5.21
3.5
2.7
0.0
0.0
g/l
0.00
60
328
74
421
1.79
5.20
1.2
1.1
—
—
—
0
0
1525
14582
1.47
5.18
18.8
10.0
26.9
25.3
u/l
2.26
1490
14070
95
583
1.67
5.11
4.5
2.9
0.7
0.6
%
1.82
88
561
44
211
2.11
5.08
1.1
1.1
—
—
—
0
0
65
358
1.85
5.08
3.6
2.7
0.0
0.0
g/l
0.00
60
329
22
76
2.92
5.04
1.4
1.5
—
—
—
0
0
22
76
2.92
5.04
1.4
1.5
—
—
—
0
0
59
316
1.90
5.02
3.4
3.3
24.5
24.9
mmol/l
0.36
53
280
156
1080
1.49
5.00
2.3
2.5
6.2
7.0
ug/l
0.26
130
940
28
111
2.55
4.97
1.1
1.0
—
—
—
0
0
19
61
3.14
4.92
1.6
1.3
—
—
—
0
0
19
61
3.14
4.92
1.6
1.3
—
—
—
0
0
27
106
2.57
4.89
1.5
1.1
65.0
81.0
u/ml
—
7
9
42
201
2.12
4.89
4.5
5.4
382.2
369.5
umol/l
0.22
35
178
10
20
5.02
4.78
1.3
1.3
—
—
—
0
0
28
115
2.46
4.64
1.7
1.2
0.5
0.6
u/ml
0.02
14
52
8
8
10.04
4.52
1.9
1.1
—
—
—
0
0
42
208
2.05
4.49
1.3
1.2
49.5
27.1
u/l
0.40
37
180
120
806
1.53
4.46
11.9
9.1
1.4
1.4
%
0.45
115
799
1303
12231
1.28
4.45
6.6
5.5
39.9
39.5
mmol/mol
0.85
1201
11324
64
367
1.77
4.43
1.2
1.1
—
—
—
0
0
22
82
2.71
4.42
1.6
1.5
3.6
7.9
u/l
0.71
14
37
52
280
1.88
4.40
1.3
1.4
—
—
—
0
0
52
280
1.88
4.40
1.3
1.4
—
—
—
0
0
68
399
1.73
4.35
3.7
2.5
37.9
37.6
g/l
0.15
62
344
67
394
1.73
4.26
5.9
5.5
1.5
1.5
mg/l
0.01
61
365
21
78
2.71
4.26
1.1
1.1
—
—
—
0
0
118
800
1.51
4.21
12.1
9.2
0.8
0.7
%
1.24
113
794
1242
11640
1.25
4.00
29.3
16.4
13.9
13.6
%
8.78
1232
11378
23
93
2.49
3.97
1.4
1.2
—
—
—
0
0
19
70
2.73
3.92
1.7
1.4
14.7
27.4
umol/l
1.62
19
63
14
43
3.27
3.91
1.2
1.2
—
—
—
0
0
312
2523
1.29
3.87
4.0
2.9
2.5
2.5
mmol/l
0.65
275
2220
23
96
2.42
3.73
1.3
1.3
—
—
—
0
0
23
97
2.39
3.65
1.3
1.3
—
—
—
0
0
14
45
3.13
3.65
1.2
1.2
—
—
—
0
0
62
374
1.68
3.64
1.4
1.3
—
—
—
0
0
11
30
3.68
3.64
1.0
1.0
—
—
—
0
0
115
801
1.47
3.63
2.1
2.2
12.1
12.2
nmol/l
0.04
103
700
16
56
2.87
3.63
5.1
1.9
18.2
157.1
ug/l
0.50
16
51
13
40
3.27
3.62
1.2
1.3
—
—
—
0
0
18
68
2.66
3.56
1.3
1.9
—
—
—
0
0
7
9
7.80
3.56
4.4
5.3
—
—
—
0
0
9
17
5.32
3.51
1.1
1.3
—
—
—
0
0
13
41
3.19
3.49
1.2
1.1
—
—
—
0
0
98
667
1.50
3.48
12.5
9.9
24.3
24.3
mmol/l
0.08
90
623
14
47
3.00
3.41
1.2
1.2
—
—
—
0
0
202
1568
1.33
3.38
1.8
1.7
1.5
1.4
%
0.07
178
1384
38
203
1.89
3.36
1.3
1.1
—
—
—
0
0
10
27
3.72
3.35
1.2
1.3
—
—
—
0
0
22
95
2.33
3.34
1.1
1.2
—
—
—
0
0
76
495
1.56
3.31
1.5
1.3
217.4
244.1
miu/ml
0.22
28
245
121
869
1.42
3.28
3.0
3.3
4.4
4.5
pmol/l
0.45
106
762
26
122
2.15
3.26
1.5
1.3
14186.7
96177.6
e6/l
0.77
18
80
15
54
2.79
3.25
1.1
1.1
134.8
181.2
iu/ml
0.65
15
54
53
317
1.69
3.24
1.8
1.7
32.4
14.4
e6/l
0.41
41
249
53
317
1.69
3.24
1.8
1.8
58.3
1417.3
e6/l
0.92
44
258
9
19
4.76
3.24
2.7
1.4
—
—
—
0
0
13
44
2.97
3.13
1.2
1.1
—
—
—
0
0
204
1604
1.31
3.12
11.2
7.0
—
—
—
0
0
13
45
2.90
3.02
1.1
1.1
—
—
—
0
0
7
12
5.85
3.02
1.3
1.3
—
—
—
0
0
171
1321
1.33
2.97
4.2
4.1
26.4
19.8
ug/l
0.20
137
1068
11
35
3.16
2.93
1.1
1.3
—
—
—
0
0
1580
15400
1.40
2.93
37.6
19.9
255.1
253.6
e9/l
0.36
1555
14999
7
13
5.40
2.87
1.0
1.4
—
—
—
0
0
1580
15411
1.38
2.81
37.5
19.9
4.4
4.5
e12/l
10.40
1555
14967
8
18
4.46
2.79
1.0
1.3
—
—
—
0
0
203
1621
1.29
2.78
4.7
4.3
32.0
32.4
%
0.18
150
1101
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
84
2.28
2.77
1.2
1.2
—
—
—
0
0
10
31
3.24
2.77
1.2
1.1
—
—
—
0
0
1580
15415
1.38
2.76
37.6
19.9
7.0
6.7
e9/l
2.89
1553
14967
1580
15417
1.38
2.74
37.7
20.0
131.2
134.3
g/l
13.32
1567
15198
46
279
1.67
2.72
2.5
2.3
124.2
129.5
g/l
0.75
37
209
8
19
4.23
2.68
1.3
1.1
—
—
—
0
0
8
19
4.23
2.68
1.3
1.1
—
—
—
0
0
23
113
2.05
2.62
1.2
1.4
—
—
—
0
0
9
25
3.61
2.57
1.1
1.2
—
—
—
0
0
25
128
1.97
2.56
8.4
3.5
—
—
—
0
0
5
7
7.16
2.55
3.0
1.4
3.0
4.8
mg/l
—
5
7
1324
12698
1.20
2.41
4.3
3.8
1.3
1.3
mmol/l
1.75
1209
11639
10
34
2.95
2.41
1.0
1.2
—
—
—
0
0
12
46
2.62
2.36
1.2
1.3
—
—
—
0
0
88
641
1.39
2.28
2.5
2.2
1429.2
5391.1
u/l
1.90
32
271
44
278
1.60
2.27
3.0
3.2
31.6
36.0
umol/l
0.71
39
237
20
99
2.03
2.26
1.1
1.2
—
—
—
0
0
7
18
3.90
2.25
1.1
1.1
—
—
—
0
0
105
790
1.35
2.23
1.3
1.3
—
—
—
0
0
35
210
1.68
2.21
1.3
1.2
4.9
5.3
u/ml
0.05
16
88
21
107
1.97
2.20
1.0
1.1
—
—
—
0
0
1356
13073
1.19
2.13
5.2
4.3
6.0
5.9
mmol/l
1.14
1235
11897
21
109
1.94
2.10
3.0
2.3
575.7
626.0
ml
0.25
15
71
9
31
2.91
2.07
1.2
1.1
73.9
96.1
%
—
9
31
32
191
1.69
2.07
2.2
2.5
4.0
26.6
u/ml
0.55
32
178
21
110
1.92
2.06
1.1
1.1
—
—
—
0
0
21
110
1.92
2.06
1.1
1.1
—
—
—
0
0
12
50
2.41
2.02
1.5
1.6
—
1224630.0
—
0
5
22
118
1.88
2.02
2.5
2.4
—
—
—
0
0
21
111
1.90
2.01
1.1
1.2
—
—
—
0
0
22
119
1.86
1.97
1.9
1.3
21571.1
90675.5
e6/l
0.70
16
67
7
21
3.34
1.96
1.4
1.1
—
—
—
0
0
21
113
1.87
1.92
1.1
1.2
45.7
40.4
mg/l
0.16
16
90
93
708
1.33
1.87
1.5
1.4
25.9
26.9
iu/l
0.11
82
603
8
29
2.77
1.79
1.1
1.1
—
—
—
0
0
26
155
1.69
1.73
1.1
1.1
—
—
—
0
0
7
24
2.92
1.72
4.9
5.8
—
—
—
0
0
5
13
3.85
1.71
1.6
1.1
—
—
—
0
0
25
148
1.70
1.70
1.1
1.1
—
—
—
0
0
1390
13498
1.17
1.67
5.1
4.7
2.7
2.7
mmol/l
1.32
1278
12426
1368
13269
1.16
1.66
4.7
4.2
4.6
4.7
mmol/l
2.57
1267
12302
5
14
3.58
1.61
1.6
1.1
9.6
29.0
u/l
—
5
9
5
14
3.58
1.61
8.6
5.9
—
—
—
0
0
11
50
2.21
1.57
1.0
1.4
75.4
92.3
%
—
5
29
33
216
1.54
1.54
1.2
1.1
14.0
85.8
iu/ml
—
9
51
1357
13175
1.15
1.54
4.6
4.2
1.4
1.5
mmol/l
3.96
1247
12137
44
307
1.44
1.53
1.1
1.1
0.7
1.8
u/ml
1.20
23
132
49
349
1.42
1.52
1.2
1.2
—
—
—
0
0
19
108
1.77
1.51
1.0
1.1
290.9
245.6
mg/l
0.31
14
92
13
65
2.01
1.48
1.7
2.1
—
—
—
0
0
60
445
1.36
1.48
1.6
1.8
—
—
—
0
0
11
52
2.12
1.44
1.0
1.1
77.2
90.1
%
—
5
30
13
66
1.98
1.43
2.7
2.5
—
—
—
0
0
17
95
1.80
1.43
1.0
1.1
11.1
8.1
iu/ml
—
8
26
19
110
1.74
1.43
1.1
1.2
—
—
—
0
0
19
110
1.74
1.43
1.1
1.2
—
—
—
0
0
63
479
1.33
1.35
3.9
3.3
7820.9
3068.8
u/ml
0.28
51
410
10
196
0.51
1.35
1.3
1.2
—
—
—
0
0
30
203
1.49
1.25
1.3
1.1
—
—
—
0
0
17
100
1.71
1.23
2.0
1.4
0.6
1.2
promille
1.29
12
79
25
163
1.54
1.23
2.4
2.3
16.8
24.4
mg/l
—
5
40
31
213
1.46
1.21
1.4
1.2
2.3
2.3
u/ml
—
9
67
13
71
1.84
1.19
1.7
1.2
9.3
11.8
u/l
0.45
13
62
25
370
0.67
1.18
2.0
1.7
—
—
—
0
0
8
38
2.11
1.18
2.1
1.0
—
—
—
0
0
69
543
1.28
1.18
2.4
1.6
398.4
306.3
mu/l
0.95
64
489
30
206
1.46
1.18
1.1
1.0
5.9
5.3
u/ml
0.11
15
70
1313
12787
1.12
1.17
25.1
14.6
38.9
39.6
%
1.78
903
9306
11
57
1.94
1.17
1.2
1.3
—
—
—
0
0
50
377
1.34
1.16
2.1
1.9
5.1
5.1
iu/l
0.02
17
134
0
34
0.00
1.16
0.0
3.1
—
1.9
—
0
26
5
20
2.50
1.15
2.2
1.3
—
—
—
0
0
346
3152
1.12
1.14
5.2
5.1
2.9
3.1
ug/l
0.10
307
2796
36
258
1.40
1.14
1.1
1.1
5.3
3.1
u/ml
0.32
11
57
7
30
2.34
1.12
1.4
1.3
—
—
—
0
0
7
30
2.34
1.12
1.9
1.3
—
—
—
0
0
31
217
1.44
1.11
1.1
1.1
—
—
—
0
0
95
783
1.23
1.11
1.0
1.0
—
—
—
0
0
15
88
1.71
1.11
1.0
2.3
—
—
—
0
0
27
184
1.47
1.11
1.0
1.1
5.8
7.1
u/ml
0.16
14
67
12
66
1.82
1.09
1.5
1.1
1667.4
1630.1
miu/ml
0.03
12
66
5
22
2.28
1.03
1.2
1.2
—
—
—
0
0
17
106
1.61
1.03
1.1
1.1
—
—
—
0
0
69
852
0.80
1.03
1.6
1.5
—
—
—
0
0
21
139
1.52
1.00
1.1
1.1
—
—
—
0
0
9
50
1.80
0.96
1.9
1.3
—
—
—
0
0
30
218
1.38
0.91
1.3
1.2
—
—
—
0
0
41
315
1.31
0.89
3.4
2.5
61.3
104.4
ug/min
0.54
25
194
25
177
1.42
0.88
1.1
1.0
0.1
0.4
u/ml
0.76
11
41
8
42
1.91
0.88
1.0
1.0
—
—
—
0
0
66
539
1.23
0.88
2.7
1.6
4.5
3.3
mg/l
0.67
49
384
34
256
1.33
0.85
3.7
3.2
0.8
0.8
nmol/l
0.04
26
202
8
46
1.74
0.82
2.1
1.4
8.3
9.2
ug/l
—
8
46
24
330
0.72
0.82
1.5
1.5
—
—
—
0
0
275
2524
1.11
0.82
4.3
4.3
20.9
21.3
%
0.16
141
1236
190
1725
1.11
0.71
2.2
2.1
—
—
—
0
0
274
2535
1.10
0.71
1.5
1.4
—
—
—
0
0
13
85
1.53
0.69
2.9
1.7
—
—
—
0
0
15
102
1.47
0.67
2.6
1.5
0.9
1.0
g/l
0.19
15
102
374
3516
1.08
0.67
1.7
1.7
1.4
1.4
mmol/l
0.72
313
2962
38
473
0.80
0.67
1.5
1.5
—
—
—
0
0
115
1020
1.14
0.64
1.2
1.2
80.3
140.2
iu/ml
2.13
41
385
5
29
1.73
0.64
1.0
1.0
63.7
40.8
u/ml
—
5
29
35
435
0.80
0.62
1.5
1.4
—
—
—
0
0
105
1183
0.88
0.61
1.4
1.6
—
—
—
0
0
5
30
1.67
0.61
1.6
1.3
—
—
—
0
0
35
434
0.80
0.61
1.5
1.4
—
—
—
0
0
35
433
0.80
0.60
1.5
1.4
—
—
—
0
0
12
80
1.50
0.59
1.1
1.1
—
—
—
0
0
35
432
0.81
0.59
1.5
1.4
—
—
—
0
0
8
54
1.48
0.57
1.6
1.6
—
—
—
0
0
34
276
1.24
0.54
2.8
1.8
1.3
0.8
nmol/l
1.17
20
230
60
516
1.17
0.53
1.5
1.4
—
—
—
0
0
47
554
0.84
0.52
1.6
1.4
—
—
—
0
0
197
1828
1.09
0.51
3.4
3.1
0.8
0.8
ug/l
0.04
145
1216
6
41
1.47
0.50
2.2
2.6
—
—
—
0
0
6
41
1.47
0.50
2.2
2.6
—
—
—
0
0
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
36
425
0.84
0.43
1.6
1.6
—
—
—
0
0
8
60
1.33
0.40
1.3
1.0
—
—
—
0
0
5
35
1.43
0.39
1.4
1.1
237.2
287.2
pmol/l
—
5
24
9
66
1.37
0.38
1.0
1.0
—
—
—
0
0
5
37
1.35
0.37
1.2
2.0
—
2.0
—
0
19
35
302
1.16
0.34
1.3
1.7
42.6
40.4
nmol/l
0.23
35
291
11
83
1.33
0.32
10.8
11.6
0.7
0.6
mmol/l
0.31
11
78
15
119
1.26
0.31
1.1
1.5
8.3
12.0
mmol/l
—
7
23
19
229
0.83
0.30
1.5
1.6
—
—
—
0
0
14
113
1.24
0.26
1.4
2.0
—
—
—
0
0
24
209
1.15
0.23
1.0
1.0
1.7
2.3
u/ml
—
8
88
198
1905
1.04
0.21
2.4
2.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
8
104
0.77
0.21
1.4
1.5
—
—
—
0
0
21
237
0.88
0.17
1.5
1.5
0.2
0.3
nmol/l
1.54
13
187
8
73
1.10
0.15
2.4
1.7
0.3
4.5
u/field
—
8
55
6
78
0.77
0.15
1.0
1.4
28.3
34.0
nmol/l
—
6
65
22
245
0.90
0.15
1.5
1.8
—
—
—
0
0
95
912
1.04
0.13
1.9
1.8
—
—
—
0
0
10
85
1.18
0.12
1.6
1.5
—
—
—
0
0
117
1134
1.03
0.11
2.1
1.9
—
—
—
0
0
10
86
1.16
0.11
1.6
1.5
—
—
—
0
0
27
290
0.93
0.10
3.6
3.4
21.1
24.5
mg/l
0.32
19
185
47
494
0.95
0.10
1.4
1.4
—
—
—
0
0
7
82
0.85
0.07
1.3
1.3
—
—
—
0
0
17
157
1.08
0.07
1.0
1.1
—
—
—
0
0
21
224
0.94
0.06
1.9
2.2
4.8
5.9
umol/l
0.37
13
163
51
523
0.97
0.04
1.5
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
7.9
—
0
8
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1766.6
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
77
0.91
0.00
4.1
14.0
501.4
824.0
nmol/l
—
7
72
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: L12_AGEP – Acute generalized exanthematous pustulosis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).